Antiplatelet drug vs control
Symptomatic intracranial haemorrhage during treatment period · acute ischaemic stroke
It is very uncertain whether antiplatelet drug changes symptomatic intracranial haemorrhage during treatment period compared with control (very low certainty).
1 finding from 1 review
- Peto OR 1.18 [0.97, 1.44]9 studies · 41652 participantsVery low